PedAM
Pediatric Disease Annotations & Medicines
| Disease | pulmonary embolism |
| Phenotype | C0006142|breast cancer |
| Sentences | 1 |
| PubMedID- 22311111 | Occurrence of coronary heart disease, stroke, pulmonary embolism, invasive breast cancer, endometrial cancer, colorectal cancer, hip fracture or death because of other causes) resulted in annual rates of 1.39% and 1.83% in the raloxifene and placebo groups, respectively (hr 0.75; 95% ci 0.62–0.92), which were compatible with a favourable risk–benefit profile for raloxifene [200]. |
Page: 1